High‐Dose Mitotane‐Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma

In response to the recently published article by Reidy‐Lagunes et al., which deals with clinical response to mitotane treatment in advanced adrenocortical carcinoma and the toxicity associated with this treatment, this letter to the editor reports a case of mitotane‐induced encephalopathy during a h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2018-03, Vol.23 (3), p.389-390
Hauptverfasser:	Pape, Elise, Feliu, Catherine, Yéléhé‐Okouma, Mélissa, Colling, Natacha, Djerada, Zoubir, Gambier, Nicolas, Weryha, Georges, Scala‐Bertola, Julien
Format:	Artikel
Sprache:	eng
Schlagworte:	Human health and pathology Letter to the Editor Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In response to the recently published article by Reidy‐Lagunes et al., which deals with clinical response to mitotane treatment in advanced adrenocortical carcinoma and the toxicity associated with this treatment, this letter to the editor reports a case of mitotane‐induced encephalopathy during a high‐dose mitotane treatment in adrenocortical carcinoma.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2017-0426